Shunmin Li

456 total citations
17 papers, 374 citations indexed

About

Shunmin Li is a scholar working on Nephrology, Clinical Biochemistry and Immunology. According to data from OpenAlex, Shunmin Li has authored 17 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 4 papers in Clinical Biochemistry and 4 papers in Immunology. Recurrent topics in Shunmin Li's work include Chronic Kidney Disease and Diabetes (10 papers), Renal Diseases and Glomerulopathies (5 papers) and Metabolism and Genetic Disorders (2 papers). Shunmin Li is often cited by papers focused on Chronic Kidney Disease and Diabetes (10 papers), Renal Diseases and Glomerulopathies (5 papers) and Metabolism and Genetic Disorders (2 papers). Shunmin Li collaborates with scholars based in China, Hong Kong and United States. Shunmin Li's co-authors include Xinhui Liu, Guoliang Xiong, Jiandong Lu, Huili Sun, Mumin Shao, Tiegang Yi, Jianping Chen, Pengxun Han, Wenjing Wang and Chunlei Zhang and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Frontiers in Pharmacology.

In The Last Decade

Shunmin Li

17 papers receiving 373 citations

Peers

Shunmin Li
Xingmei Yao China
Peichun Zhang China
Lirong Liu China
Shudong Yang China
Jufang Yao China
Maohua Pei China
Xinxin Xia China
Wei Xing China
Xingmei Yao China
Shunmin Li
Citations per year, relative to Shunmin Li Shunmin Li (= 1×) peers Xingmei Yao

Countries citing papers authored by Shunmin Li

Since Specialization
Citations

This map shows the geographic impact of Shunmin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shunmin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shunmin Li more than expected).

Fields of papers citing papers by Shunmin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shunmin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shunmin Li. The network helps show where Shunmin Li may publish in the future.

Co-authorship network of co-authors of Shunmin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shunmin Li. A scholar is included among the top collaborators of Shunmin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shunmin Li. Shunmin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Li, Yuyan, et al.. (2025). Network pharmacology and multi-omics validation of the Jianpi-Yishen formula in the treatment of chronic kidney disease. Frontiers in Immunology. 15. 1512519–1512519. 1 indexed citations
2.
3.
Liu, Xinhui, et al.. (2022). Lipidomics reveals the potential mechanism of honokiol against adenine-induced chronic kidney disease. Frontiers in Pharmacology. 13. 1019629–1019629. 9 indexed citations
4.
Liu, Xinhui, Yulian Chen, Shiying Huang, et al.. (2022). Jian-Pi-Yi-Shen Formula Improves Adenine-Induced Chronic Kidney Disease via Regulating Tryptophan Metabolism and Aryl Hydrocarbon Receptor Signaling. Frontiers in Pharmacology. 13. 922707–922707. 16 indexed citations
5.
Luo, Yue, et al.. (2022). The effects of natural products and bioactive ingredients of traditional Chinese medicine on apoptosis of ovarian granulosa cells. Journal of Applied Toxicology. 43(6). 772–788. 2 indexed citations
6.
Li, Yuyan, Xinhui Liu, Siqi Liu, et al.. (2020). Untargeted Metabolomics Reveals the Protective Effect of a Traditional Chinese Herbal Decoction on Cisplatin‐Induced Acute Kidney Injury. Evidence-based Complementary and Alternative Medicine. 2020(1). 8524132–8524132. 4 indexed citations
7.
Zhang, Bing, et al.. (2020). Astragaloside IV alleviates puromycin aminonucleoside-induced podocyte cytoskeleton injury through the Wnt/PCP pathway.. PubMed. 12(7). 3512–3521. 9 indexed citations
8.
Liu, Xinhui, Jiandong Lu, Yijun Chen, et al.. (2019). Dihydroartemisinin attenuates lipopolysaccharide-induced acute kidney injury by inhibiting inflammation and oxidative stress. Biomedicine & Pharmacotherapy. 117. 109070–109070. 79 indexed citations
9.
Yang, Yilong, et al.. (2018). Trichosanthes kirilowii lectin ameliorates streptozocin-induced kidney injury via modulation of the balance between M1/M2 phenotype macrophage. Biomedicine & Pharmacotherapy. 109. 93–102. 45 indexed citations
10.
Chen, Jianping, Amy G. W. Gong, Xiaoyan Liu, et al.. (2018). A Chinese herbal decoction, Jian-Pi-Yi-Shen, regulates the expressions of erythropoietin and pro-inflammatory cytokines in cultured cells. BMC Complementary and Alternative Medicine. 18(1). 119–119. 13 indexed citations
11.
Lu, Jiandong, et al.. (2018). Jian‐Pi‐Yi‐Shen Formula Regulates Inflammatory Cytokines Production in 5/6 Nephrectomized Rats via Suppression of NF‐κB Activation. Evidence-based Complementary and Alternative Medicine. 2018(1). 7203547–7203547. 19 indexed citations
12.
Liu, Xinhui, Jianping Chen, Xiaoyan Liu, et al.. (2018). Jian-Pi-Yi-Shen Formula ameliorates chronic kidney disease: involvement of mitochondrial quality control network. BMC Complementary and Alternative Medicine. 18(1). 24 indexed citations
13.
Han, Pengxun, Huili Sun, Mumin Shao, et al.. (2018). Astragaloside IV ameliorates early diabetic nephropathy by inhibition of MEK1/2-ERK1/2-RSK2 signaling in streptozotocin-induced diabetic mice. Journal of International Medical Research. 46(7). 2883–2897. 28 indexed citations
14.
Sun, Huili, Wenjing Wang, Pengxun Han, et al.. (2016). Astragaloside IV ameliorates renal injury in db/db mice. Scientific Reports. 6(1). 32545–32545. 50 indexed citations
15.
Zhang, Chunlei, et al.. (2015). Immunoglobulin A nephropathy: current progress and future directions. Translational research. 166(2). 134–144. 38 indexed citations
16.
Sun, Huili, Mumin Shao, Xiaoyan Cheng, et al.. (2013). Lumbrokinase attenuates diabetic nephropathy through regulating extracellular matrix degradation in Streptozotocin-induced diabetic rats. Diabetes Research and Clinical Practice. 100(1). 85–95. 26 indexed citations
17.
Li, Shunmin. (1997). Effect of Qiangji Jianli Capsule on Metabolism of Acetylcholine Receptor. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xingmei Yao Breakdown of academic impact, for papers by Peichun Zhang Breakdown of academic impact, for papers by Lirong Liu Breakdown of academic impact, for papers by Shudong Yang Breakdown of academic impact, for papers by Jufang Yao Breakdown of academic impact, for papers by Maohua Pei Breakdown of academic impact, for papers by Xinxin Xia Breakdown of academic impact, for papers by Wei Xing
Rankless by CCL
2026